FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.8.7  |  FHIR Version n/a  User: [n/a]

8940801000001103: Re-introduced (qualifier value)


Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-Oct 2007. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
40298601000001113 Re-introduced (qualifier value) en Fully specified name Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module
40298701000001115 Re-introduced en Synonym Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Re-introduced Is a Non-availability indicator true Inferred relationship Existential restriction modifier

Inbound Relationships Type Active Source Characteristic Refinability Group
Vapour-permeable adhesive film dressing 10cm x 14cm 50 dressing VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Premierfilm I.V. dressing 10cm x 14cm (Shermond) VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Vapour-permeable adhesive film dressing 10cm x 14cm 1 dressing VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Cutifilm dressing 10cm x 14cm (Smith & Nephew Healthcare Ltd) VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Vapour-permeable adhesive film dressing 10cm x 14cm 10 dressing VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Cutifilm dressing 10cm x 14cm (Smith & Nephew Healthcare Ltd) 50 dressing VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Premierfilm I.V. dressing 10cm x 14cm (Shermond) 10 dressing VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Premierfilm I.V. dressing 10cm x 14cm (Shermond) 1 dressing VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Cutifilm dressing 10cm x 14cm (Smith & Nephew Healthcare Ltd) 1 dressing VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Ustekinumab 45mg/0.5ml solution for injection vials VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Stelara 45mg/0.5ml solution for injection vials (Janssen-Cilag Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Ustekinumab 45mg/0.5ml solution for injection vials 1 vial VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Stelara 45mg/0.5ml solution for injection vials (Janssen-Cilag Ltd) 1 vial VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Magnesium oxide 160mg tablets VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Magnesium oxide 160mg tablets 120 tablet VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Oromag 160 tablets (Fontus Health Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Magdose 160mg tablets (TriOn Pharma Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Magnesium oxide 160mg tablets 30 tablet VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Oromag 160 tablets (Fontus Health Ltd) 120 tablet VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Magdose 160mg tablets (TriOn Pharma Ltd) 30 tablet VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Oromag 160 tablets (Fontus Health Ltd) 30 tablet VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Healthgard Film+ dressing 6cm x 7cm (Shermond) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Advocate lancets 0.31mm/30gauge (Diabetes Care Technology Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
GlucoRx Safety lancets 1.8mm/26gauge (GlucoRx Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Glucoject hypodermic insulin needles for pre-filled / reusable pen injectors screw on 10mm/29gauge (A Menarini Diagnostics Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Healthgard Film+ dressing 6cm x 7cm (Shermond) 1 dressing VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Healthgard Film+ dressing 6cm x 7cm (Shermond) 10 dressing VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Advocate lancets 0.31mm/30gauge (Diabetes Care Technology Ltd) 100 lancet VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
GlucoRx Safety lancets 1.8mm/26gauge (GlucoRx Ltd) 100 lancet VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Glucoject hypodermic insulin needles for pre-filled / reusable pen injectors screw on 10mm/29gauge (A Menarini Diagnostics Ltd) 100 needle VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Nurofen Sinus & Blocked Nose 200mg/5mg tablets (Reckitt Benckiser Healthcare (UK) Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Nurofen Sinus Pain Relief 200mg/5mg tablets (Reckitt Benckiser Healthcare (UK) Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Nurofen Sinus & Blocked Nose 200mg/5mg tablets (Reckitt Benckiser Healthcare (UK) Ltd) 16 tablet 2 x 8 tablets VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Nurofen Sinus Pain Relief 200mg/5mg tablets (Reckitt Benckiser Healthcare (UK) Ltd) 16 tablet 2 x 8 tablets VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Leuprolide acetate 3.75mg powder for injection solution + diluent VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Prostap SR 3.75mg powder and solvent for suspension for injection vials (Sigma Pharmaceuticals Plc) VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Prostap SR 3.75mg powder and solvent for suspension for injection vials (Mawdsley-Brooks & Company Ltd) VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Leuprorelin 3.75mg powder and solvent for suspension for injection vial 1 vial VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Prostap SR 3.75mg powder and solvent for suspension for injection vials (Wyeth Laboratories) VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Prostap SR 3.75mg powder and solvent for suspension for injection vials (PI) (Waymade Ltd) VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Lutrate 1 month Depot 3.75mg powder and solvent for suspension for injection vials (AMCo) VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Prostap SR 3.75mg powder and solvent for suspension for injection vials (Doncaster Pharmaceuticals Ltd) VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Prostap SR 3.75mg powder and solvent for suspension for injection vials (Lexon (UK) Ltd) VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Prostap SR 3.75mg powder and solvent for suspension for injection vials (Necessity Supplies Ltd) VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Prostap SR 3.75mg powder and solvent for suspension for injection vials (Sigma Pharmaceuticals Plc) 1 vial VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Prostap SR 3.75mg powder and solvent for suspension for injection vials (Mawdsley-Brooks & Company Ltd) 1 vial VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Lutrate 1 month Depot 3.75mg powder and solvent for suspension for injection vials (AMCo) 1 vial VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Prostap SR 3.75mg powder and solvent for suspension for injection vials (Wyeth Laboratories) 1 vial VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Prostap SR 3.75mg powder and solvent for suspension for injection vials (PI) (Waymade Ltd) 1 vial VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Prostap SR 3.75mg powder and solvent for suspension for injection vials (Lexon (UK) Ltd) 1 vial VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Prostap SR 3.75mg powder and solvent for suspension for injection vials (Doncaster Pharmaceuticals Ltd) 1 vial VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Prostap SR 3.75mg powder and solvent for suspension for injection vials (Necessity Supplies Ltd) 1 vial VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Losartan 25mg tablets (Mawdsley-Brooks & Company Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Metaraminol 10mg/1ml solution for injection ampoules (Torbay Pharmaceuticals) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Sodium lactate compound (Hartmann's Solution) infusion 500ml polyethylene bottles 12 bottle VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Metaraminol 10mg/1ml solution for injection ampoules 10 ampoule VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Losartan 25mg tablets (Mawdsley-Brooks & Company Ltd) 28 tablet VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Metaraminol 10mg/1ml solution for injection ampoules (Torbay Pharmaceuticals) 10 ampoule VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Polyfusor H sodium lactate compound (Hartmann's Solution) infusion 500ml bottles (Fresenius Kabi Ltd) 12 bottle VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Etoposide 500mg/25ml solution for injection vials VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Etoposide 500mg/25ml concentrate for solution for infusion vials (A A H Pharmaceuticals Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Etoposide 500mg/25ml solution for injection vials 1 vial VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Eposin 500mg/25ml solution for injection vials (Medac GMBH) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Etoposide 500mg/25ml solution for injection vials 10 vial VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Etoposide 500mg/25ml concentrate for solution for infusion vials (Teva UK Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Eposin 500mg/25ml solution for injection vials (Medac GMBH) 1 vial VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Etoposide 500mg/25ml concentrate for solution for infusion vials (A A H Pharmaceuticals Ltd) 1 vial VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Eposin 500mg/25ml solution for injection vials (Medac GMBH) 10 vial VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Etoposide 500mg/25ml concentrate for solution for infusion vials (Teva UK Ltd) 1 vial VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Ramipril 1.25mg capsules (Mawdsley-Brooks & Company Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Ramipril 2.5mg capsules (Mawdsley-Brooks & Company Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Ramipril 5mg capsules (Mawdsley-Brooks & Company Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Ramipril 1.25mg capsules (Mawdsley-Brooks & Company Ltd) 28 capsule VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Ramipril 2.5mg capsules (Mawdsley-Brooks & Company Ltd) 28 capsule VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Ramipril 5mg capsules (Mawdsley-Brooks & Company Ltd) 28 capsule VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Product containing precisely chlorpromazine hydrochloride 10 milligram/1 each conventional release oral tablet VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Coal tar solution 10% cream VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Product containing precisely cimetidine 40 milligram/1 milliliter conventional release oral suspension VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Chlorpromazine 10mg tablets 56 tablet VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Cimetidine 200mg/5ml oral suspension sugar free (Special Order) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Dyspamet 200mg/5ml suspension (Goldshield Healthcare Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Cimetidine 200mg/5ml oral suspension sugar free 600 ml VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Coal tar solution 10% cream 30 gram VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Carbo-Dome 10% cream (PI) (Waymade Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Chlorpromazine 10mg tablets 1 tablet VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Cimetidine 200mg/5ml oral suspension sugar free (Rosemont Pharmaceuticals Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Coal tar solution 10% cream 100 gram VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Carbo-Dome 10% cream (Sandoz Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Cimetidine 200mg/5ml oral suspension sugar free 1 ml VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Cimetidine 200mg/5ml oral suspension sugar free 300 ml VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Chlorpromazine 10mg tablets (Special Order) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Largactil 10mg tablets (Hawgreen Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Coal tar solution 10% cream 1 gram VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Coal tar solution 10% cream (Special Order) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Largactil 10mg tablets (Hawgreen Ltd) 56 tablet 2 x 28 tablets VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Chlorpromazine 10mg tablets (Special Order) 1 tablet VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Cimetidine 200mg/5ml oral suspension sugar free (Special Order) 1 ml VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Coal tar solution 10% cream (Special Order) 1 gram VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Carbo-Dome 10% cream (Sandoz Ltd) 100 gram VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Carbo-Dome 10% cream (PI) (Waymade Ltd) 100 gram VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Carbo-Dome 10% cream (Sandoz Ltd) 30 gram VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier

Start Previous Page 66 of 86 Next End


This concept is not in any reference sets

Back to Start